Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03525-6
Abstract: Several studies have evaluated the role of delayed initiation of adjuvant chemotherapy (AC) in breast cancer (BC), but the results have remained controversial and an optimal time has not been defined. Our aim was to… read more here.
Keywords: adjuvant chemotherapy; chemotherapy breast; breast cancer; cancer ... See more keywords
Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Computer Assisted Tomography"
DOI: 10.1097/rct.0000000000000978
Abstract: Objective The objective of this study was to develop a nomogrom for prediction of pathological complete response (PCR) to neoadjuvant chemotherapy in breast cancer patients. Methods Ninety-one patients were analyzed. A total of 396 radiomics… read more here.
Keywords: neoadjuvant chemotherapy; chemotherapy breast; pathological complete; complete response ... See more keywords
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.819405
Abstract: Breast cancer (BC) is the most common malignancy among females. Chemotherapy drugs remain the cornerstone of treatment of BC and undergo significant shifts over the past 100 years. The advent of immunotherapy presents promising opportunities… read more here.
Keywords: properties chemotherapy; breast cancer; immunostimulatory properties; chemotherapy breast ... See more keywords